Revolutionary drug for schizophrenia wins US approval
Elie Dolgin • September 26, 2024
The medication is the first in decades to have a different mode of action than do current drugs, achieving better symptom relief with fewer side effects.
Read at Nature.
Paul Mischel is championing the importance of odd rings of DNA in tumors — and their promise as targets for cancer therapy.
Edits create cells that don’t trigger an immune response, allowing implant recipient to forego immune-suppressing drugs.